Specific cellular tRNA isoacceptors are packaged into retroviruses during viral assembly, and some of these are annealed onto the primer-binding site of viral genomic RNA and used to initiate the synthesis of minus-strand cDNA by reverse transcriptase. Different primer tRNAs are used by different retroviral families. tRNA Trp is the primer for all members of the avian sarcoma virus-avian leukosis virus group (19, 20, 24) . The major tRNA Lys isoacceptors in mammalian cells are tRNA 1, 2 Lys and tRNA 3 Lys , the latter being the primer tRNA for reverse transcriptase in lentiviruses, including human immunodeficiency virus type 1 (HIV-1) (18) . Primer tRNAs are selectively packaged into retroviruses during their assembly, i.e., their relative concentration in the low-molecular-weight RNA population increases in moving from the cytoplasm to the virus. For example, the relative concentration of tRNA Trp has been reported to increase from 1.4% to 32% in avian myeloblastosis virus (24) while tRNA Lys (i.e., tRNA 1,2 Lys and tRNA 3 Lys ) increases from 5 to 6% in the cytoplasm to 50 to 60% in HIV-1 (16) . On the other hand, selective packaging of primer tRNA Pro in Moloney murine leukemia virus (MoMuLV) has been reported to be much less, with the relative concentration of tRNA Pro within low-molecular-weight RNA changing from 5 to 6% in the cytoplasm to 12 to 24% in the virion (24) . Furthermore, while mutations in the reverse transcriptase eliminate selective packaging of primer tRNA in all three of these retroviruses, primer tRNA annealing to the viral genome is reduced in only HIV-1 and the avian retroviruses and not in Mo-MuLV (7, (14) (15) (16) 19) . Increases in the concentration of primer tRNA 3 Lys in HIV-1 result in both greater tRNA 3 Lys annealing to the genome and greater viral infectivity (8) .
It was recently reported that human lysyl-tRNA synthetase (LysRS), the enzyme that aminoacylates tRNA Lys , is also selectively packaged into HIV-1 (2). In contrast, two other aminoacyl-tRNA synthetases (aaRSs), isoleucyl-tRNA synthetase and prolyl-tRNA synthetase (ProRS), were not detected in HIV-1 (2). This result suggests that LysRS may represent the factor which signals HIV-1 proteins to interact with a tRNA Lys / LysRS complex for selective packaging of tRNA Lys into the virus. This hypothesis is further strengthened by studies with tRNA 3 Lys anticodon mutants showing that the extent of tRNA 3
Lys aminoacylation is directly correlated with its incorporation into the virion (11) . This suggests that productive tRNA 3 Lys interaction with LysRS is a prerequisite for packaging. The aim of the present study was to determine whether the cognate aaRS for primer tRNAs in Rous sarcoma virus (RSV) and Mo-MuLV (i.e., tryptophanyl-tRNA synthetase [TrpRS] and ProRS, respectively) are also selectively packaged into the virion.
Purified HIV-1, RSV, and Mo-MuLV were obtained from HIV-1-transfected human 293T cells, RSV-infected turkey embryo fibroblasts (TEFs), and Mo-MuLV-infected murine NIH 3T3 cells as described in the legend to Fig. 1 . Figure 1A shows Western blots of lysates from HIV-1, RSV, and Mo-MuLV, probed, respectively, with mouse antiserum to CAp24, rabbit antiserum to CAp27, and rabbit antiserum to . Rabbit antisera to these aaRSs were isolated following three subcutaneous injections of purified protein with 3-to 4-week intervals between injections (150 to 300 g of total protein). The isolations of human LysRS (21) and TrpRS (23) were as previously described. Human ProRS is derived from the C-terminal domain (amino acid residues 926 to 1440) of GluProRS and was purified as described previously (9) . Western blots were analyzed by enhanced chemiluminescence (ECL kit; Amersham Life Sciences) with goat antimouse or donkey anti-rabbit antibody (Amersham Life Sciences) as a secondary antibody. The sizes of the detected protein bands were estimated by using prestained high-molecular-mass protein markers (GIBCO/BRL), represented by the numbers to the left of each panel. V, viral lysate; C, cell lysate.
FIG. 2. Quantitation of LysRS in HIV-1. (A)
Western blots probed with anti-LysRS. Purified viruses and cells were lysed by suspension in 1ϫ radioimmunoprecipitation assay buffer, and 100 g of cell lysate protein or 30 g of viral lysate protein was resolved by sodium dodecyl sulfate-10% polyacrylamide gel electrophoresis, followed by blotting onto nitrocellulose membranes and probing with anti-human LysRS. (B) Total viral RNA from 30 g of viral protein of HIV-1 was extracted by the guanidinium isothiocyanate procedure (4). HIV-1 genomic RNA was measured by dot blot hybridization with a radioactive DNA probe specific for the HIV-1 genomic RNA sequence from nucleotides 338 to 354. (C) The first seven lanes in the Western blot shown in panel A contained decreasing amounts of His 6 -human LysRS, purified on Niϩ columns as previously described (21) In Fig. 1D , a Western blot was probed with rabbit antihuman ProRS. The two major species seen in 293T cells migrated with M r s of approximately 160,000 and 55,000. In higher eukaryotes, such as the rat (22) and Drosophila melanogaster (3), sheep (13) , and humans (6, 12) , ProRS is the C-terminal part of a fusion with glutamyl-tRNA synthetase, and the large species on this gel corresponds to the human glutamyl-prolyltRNA synthetase (GluProRS) fusion protein. The smaller species migrates according to purified human ProRS, which has an M r of approximately 55,000 to 60,000. The lower-molecularweight band was also seen in the cytoplasm of TEFs (lane 4) and murine NIH 3T3 cells (lane 6). In TEFs, the larger species was detected as a protein with an M r of 80,000, while the larger species in murine NIH 3T3 cells (lane 6) migrated somewhat faster than the large species found in the human 293T cells.
ProRS was not detected in HIV-1, RSV, or Mo-MuLV (lanes 1, 3, and 5).
We next determined the number of molecules of LysRS and TrpRS present in HIV-1 and RSV and in the cells producing these viruses. Human His 6 -LysRS was expressed in bacteria and purified as previously described (21) . Human TrpRS was purified from Escherichia coli as previously described (23) . Western blots of known amounts of purified LysRS ( Fig. 2A,  lanes 1 to 7) or TrpRS (Fig. 3A, lanes 1 to 7) were quantitated by phosphorimaging and used to generate the LysRS and TrpRS standard curves shown in Fig. 2C and 3C , respectively. These curves were used to quantitate the amount of LysRS and TrpRS present in viral and cell lysates. Total protein in the viral and cell lysates was determined by the Bradford assay (1), and the nanograms of aaRS/microgram of protein for both the cell and viral lysates are listed in Table 1 . The standard curves in Fig. 2 and 3 indicate the lower limit of detection of either LysRS or TrpRS at approximately 0.15 ng, and this was used to calculate the limits of detection listed in Table 1 when no aaRS signal was detected. In both human 293T cells and TEFs, the relative concentrations of LysRS and TrpRS were very similar. However, whereas the relative amount of LysRS in HIV-1 was comparable to that found in the cell lysate, TrpRS was not detected in HIV-1. Similarly, the relative amount of TrpRS in RSV was similar to the amount found in TEFs whereas LysRS was not detected in RSV (Table 1) . Viruses with large differences in the relative concentrations of LysRS and TrpRS were produced in cells in which there was little difference in the cytoplasmic concentrations of these two aaRSs. This indicates the existence of a selective packaging mechanism for the aaRS cognate to the primer tRNA found in either HIV-1 or RSV.
To determine the number of aaRS molecules/virion, we first Fig. 2A , except purified LysRS was replaced with purified TrpRS, and the blot was probed with antihuman TrpRS. The expression of TrpRS in E. coli and its purification were done as previously described (23) For the PCR, a sense primer (5Ј GGA TCC TAA TAC GAC TCA TAG GGA GAA ACA ACT GTG CAG CGA GAT 3Ј) was used to introduce a T7 promoter 5Ј terminal to the amplified fragment and an antisense primer sequence (5Ј CCT TGG CCC TGC TCT CCC A 3Ј) was used. Then the purified PCR product was used as a template to in vitro transcribe RSV genomic RNA, and a standard curve was established by using known amounts of this synthetic RNA (panel B, lanes 1 to 7). This curve was used to establish the concentration of viral RNA in the RSV RNA sample in lane 8 of panel B. The mock lane (lane 9) contained a total RNA preparation from the culture medium of nontransfected TEF cells. (Fig. 4B) . Standard curves were established by using known amounts of synthetic viral RNA, which were transcribed in vitro from PCR-amplified fragments encoding HIV-1 nucleotides 473 to 1420 (Fig. 2B and D) , RSV nucleotides 763 to 956 (Fig. 3B and D) , or Mo-MuLV nucleotides 456 to 797 (Fig. 4B and D) . Based on the data shown in Fig. 2 and 3 , and assuming there were two RNA molecules/ virion, we estimated the amounts of LysRS in HIV and TrpRS in RSV to be approximately 25 and 12 molecules, respectively (Table 1) . These estimates were determined by assuming that the genomic RNA probes hybridize with equal efficiency to both the full-length viral RNA in our samples and the much shorter synthetic RNA fragments used to generate the genomic RNA standard curves.
FIG. 3. Quantitation of TrpRS in RSV. (A) A Western blot was prepared similar to that shown in
As shown in Fig. 1 and 4, we were unable to detect ProRS in Mo-MuLV. The standard ProRS curve in Fig. 4 indicates a lower limit of detection of ProRS at approximately 0.15 ng, and this was used to calculate the numbers listed in Table 1 when no aaRS signal was detected. Based upon this, we were unable to detect the presence of ProRS in fewer than 1.6 molecules/ virion. These data also indicate that the concentration of ProRS was 0.061 Ϯ 0.018 ng/g of NIH 3T3 cell protein, i.e., very similar to the cellular concentrations of LysRS and TrpRS shown in Table 1 .
The similarity between the number of molecules of LysRS/ virion and the previously determined number of tRNA Lys molecules/virion (20 to 25 [10] ) supports the hypothesis that LysRS is a limiting factor in tRNA Lys incorporation into HIV-1. (Indeed, overexpression of LysRS in HIV-1-transfected cells doubles the number of tRNA Lys molecules/virion [8] .) The tRNA Trp content in RSV has not been reported, but the determined number of avian TrpRS molecules in RSV may be an underestimate since the standard on which it was based (Fig.  3C ) used antibodies specific for human TrpRS and differences which may exist between human and avian TrpRS may reduce the antibody's affinity for avian TrpRS.
Our data indicate that the aaRS cognate to the primer tRNA in both HIV-1 and RSV is selectively packaged into the virion and supports the hypothesis that aaRS may act as a signal for targeting the primer tRNA for incorporation into these viruses. On the other hand, our inability to detect ProRS in Mo-MuLV is further evidence (7, 14, 15) that the mechanism for ensuring optimal primer tRNA annealing to the viral genome in HIV-1 and avian retroviruses, i.e., selective packaging, is of less importance in Mo-MuLV. The mock lane (lane 9) contained a total RNA preparation from the culture medium of nontransfected murine NIH 3T3 cells.
